Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

What's Behind the Move in Genus plc Shares?

Daily Change:+56.00p (up 2.48%) as of the latest session

Ishan Mudgal | 06 August 2026

What's Behind the Rally in Hikma Pharmaceuticals plc Shares?

Daily Change:+162.00p (up 10.31%) as of the latest session

Ishan Mudgal | 06 August 2026

Is Oxford Biomedica plc Building on Recent Strength?

Daily Change:+13.00p (up 2.27%) as of the latest session

Ishan Mudgal | 06 August 2026

Is Oxford Nanopore Technologies plc Gaining Momentum?

Daily Change:+2.40p (up 2.05%) as of the latest session

Ishan Mudgal | 06 August 2026

Why GSK's Vaccines and Specialty Medicines Pipeline Keeps Investors Engaged

GSK PLC (LSE:GSK) gained0.94% on 6th August 2026, according to the market data provided, as investors assessed the company's business fundamentals, sector positioning and broader market conditions.

Divya Sood | 06 August 2026

Why Convatec's Medical Technology Niche Keeps Attracting Steady Demand

Convatec Group PLC (LSE:CTEC) gained0.89% on 6th August 2026, according to the market data provided, as investors assessed the company's business fundamentals, sector positioning and broader market conditions.

Divya Sood | 06 August 2026

AstraZeneca Reaches Ex-Dividend Day With Its Growth Premium Under the Microscope

Holders of Britain's largest listed company will notice something on their screens this morning that looks, at a glance, like a fall. From today, 6 August 2026, AstraZeneca (LSE:AZN) shares trade ex-dividend for the group's first interim payment of the 2026 financial year. Anyone …

Divya Sood | 06 August 2026

Is CVS Group plc Building on Recent Gains?

Daily Change:+7.00p (up 0.54%) as of the latest session

Ishan Mudgal | 06 August 2026

Why Consumer Trust in Everyday Health Brands Is Lifting Haleon

Haleon PLC (LSE:HLN) gained1.89% on 6th August 2026, according to the market data provided, as investors assessed the company's business fundamentals, sector positioning and broader market conditions.

Divya Sood | 06 August 2026

Nuformix Slides Nearly 12% as Investors Lose Patience With the Biotech Recovery Story

Shares in Nuformix (LSE:NFX), the AIM-quoted pharmaceutical development company, closed at 0.135p on 5 August 2026, down 0.019p, or 11.84%, on the day, according to London South East's "All-Share Fallers" data. On the face of it, that is a steep drop. In cash terms …

Divya Sood | 06 August 2026
Support

Hi! How can we help you today?

Loading…